CPRX
NASDAQ · Biotechnology
Catalyst Pharmaceuticals Inc
$23.32
+0.53 (+2.33%)
CPRX News5 articles
HKEX Eyes IPO Revival and Policy Signals as Key Catalysts
HKEX shares gained 0.87% to HK$419.00, with a revived IPO pipeline and upcoming policy meetings in Beijing setting the near-term agenda. The exchange reported record 2025 profits of HK$17.8 billion.
Fortescue Faces Dual Catalysts with Mine Review and Earnings
Fortescue Metals Group shares gained 0.5% as regulators began a public comment period for its proposed Wyloo North iron ore mine, with investors also positioning for the company's half-year financial results scheduled for February 25.
Instacart Parent Soars on Strong Guidance, Eyes Key Catalysts Ahead
Maplebear Inc, parent of Instacart, closed up 9.2% at $36.30 following an upbeat quarterly forecast. The company reported a 14% rise in Q4 gross transaction value to $9.85 billion.
Intel Recovers Slightly After Sharp Sell-Off, Focus Shifts to Upcoming Catalysts
Intel shares edged higher in premarket trading Wednesday, attempting to stabilize after a 6% decline. Investors are assessing macro risks and awaiting the company's upcoming presentation at Mobile World Congress.
Reliance Industries Faces Dual Catalysts: Russian Crude Shift and Australian Acquisition
Reliance Industries shares are poised for attention as reports indicate Indian refiners are avoiding new Russian crude contracts, while its consumer arm secures a majority stake in Australia's Goodness Group.